Integrative metabonomics as potential method for diagnosis of thyroid malignancy

[1]  R. Seethala,et al.  Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay , 2014, Cancer.

[2]  Ji-Xin Cheng,et al.  Direct Visualization of De novo Lipogenesis in Single Living Cells , 2014, Scientific Reports.

[3]  Huiru Tang,et al.  High-fat diet induces dynamic metabolic alterations in multiple biological matrices of rats. , 2013, Journal of proteome research.

[4]  Huiru Tang,et al.  Gallic acid intake induces alterations to systems metabolism in rats. , 2013, Journal of proteome research.

[5]  M. Miccoli,et al.  Metabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based study. , 2012, Surgery.

[6]  Chengwei He,et al.  Inhibiting Delta-6 Desaturase Activity Suppresses Tumor Growth in Mice , 2012, PloS one.

[7]  Feng Zhang,et al.  Dysregulated lipid metabolism in cancer. , 2012, World journal of biological chemistry.

[8]  Darya Chudova,et al.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.

[9]  M. A. Marcello,et al.  mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation. , 2012, Pathology, research and practice.

[10]  Hui Yang,et al.  Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. , 2012, Genes & development.

[11]  Huiru Tang,et al.  Metabonomic analysis reveals the CCl4-induced systems alterations for multiple rat organs. , 2012, Journal of proteome research.

[12]  F. Basolo,et al.  Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of study. , 2012, Journal of proteome research.

[13]  Chang-Sheng Li,et al.  Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China , 2011, Diagnostic pathology.

[14]  C. Larsson,et al.  Proteomic profiling of follicular and papillary thyroid tumors , 2011, European journal of endocrinology.

[15]  Peiyuan Yin,et al.  Serum metabolic profiling and features of papillary thyroid carcinoma and nodular goiter. , 2011, Molecular bioSystems.

[16]  Sebastian Munck,et al.  De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. , 2010, Cancer research.

[17]  J. Mechanick,et al.  Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications , 2010, Journal of cellular physiology.

[18]  R. Paschke,et al.  Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns , 2010, Molecular and Cellular Endocrinology.

[19]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[20]  Huiru Tang,et al.  Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of Salvia Miltiorrhiza Bunge. , 2010, Journal of proteome research.

[21]  Huiru Tang,et al.  Combined NMR and LC-MS analysis reveals the metabonomic changes in Salvia miltiorrhiza Bunge induced by water depletion. , 2010, Journal of proteome research.

[22]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[23]  K. Krause,et al.  Proteomics in thyroid tumor research. , 2009, The Journal of clinical endocrinology and metabolism.

[24]  C. Thompson,et al.  The molecular determinants of de novo nucleotide biosynthesis in cancer cells. , 2009, Current opinion in genetics & development.

[25]  Johan Trygg,et al.  CV‐ANOVA for significance testing of PLS and OPLS® models , 2008 .

[26]  J. Lindon,et al.  Systems biology: Metabonomics , 2008, Nature.

[27]  J. Carretero,et al.  Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels. , 2008, Nitric oxide : biology and chemistry.

[28]  J. Kurhanewicz,et al.  Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR‐MAS spectroscopy of biopsy tissues , 2008, Magnetic resonance in medicine.

[29]  F. Pattou,et al.  Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease. , 2008, Thyroid : official journal of the American Thyroid Association.

[30]  K. Zeller,et al.  Global Regulation of Nucleotide Biosynthetic Genes by c-Myc , 2008, PloS one.

[31]  Qiang Yu,et al.  Saturated Fatty Acids Modulate Cell Response to DNA Damage: Implication for Their Role in Tumorigenesis , 2008, PloS one.

[32]  Yong Yue,et al.  Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. , 2007, Journal of proteome research.

[33]  Y. Liu,et al.  Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer , 2006, Prostate Cancer and Prostatic Diseases.

[34]  E. Gottlieb,et al.  Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.

[35]  D. Farley,et al.  Thyroid nodules: does the suspicion for malignancy really justify the increased thyroidectomy rates? , 2006, Surgical oncology.

[36]  T. Teknos,et al.  Evaluation of the thyroid nodule. , 2006, Cancer control : journal of the Moffitt Cancer Center.

[37]  Angel Ortega,et al.  Glutathione in Cancer Biology and Therapy , 2006, Critical reviews in clinical laboratory sciences.

[38]  S. Canevari,et al.  Alterations of choline phospholipid metabolism in ovarian tumor progression. , 2005, Cancer research.

[39]  H. Gharib,et al.  Continuing Controversies in the Management of Thyroid Nodules , 2005, Annals of Internal Medicine.

[40]  J. Trygg,et al.  Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. , 2005, Analytical chemistry.

[41]  G. Balendiran,et al.  The role of glutathione in cancer , 2004, Cell biochemistry and function.

[42]  H. Gharib,et al.  Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[43]  R. Somorjai,et al.  An ex vivo study exploring the diagnostic potential of 1H magnetic resonance spectroscopy in squamous cell carcinoma of the head and neck region , 2002, Head & neck.

[44]  S. Wold,et al.  Orthogonal projections to latent structures (O‐PLS) , 2002 .

[45]  J. Carretero,et al.  γ‐Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver , 2002, Hepatology.

[46]  R. Weiss,et al.  Thyroid nodules: diagnosis and therapy , 2002, Current opinion in oncology.

[47]  H. Gharib,et al.  Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas. , 2001, Thyroid : official journal of the American Thyroid Association.

[48]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[49]  A. Fujioka,et al.  Relationship between Protein Levels and Gene Expression of Dihydropyrimidine Dehydrogenase in Human Tumor Cells during Growth in Culture and in Nude Mice , 1998, Japanese journal of cancer research : Gann.

[50]  J. Sludden,et al.  Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. , 1998, British Journal of Cancer.

[51]  R. Gonzalez,et al.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  R. Ozols,et al.  Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines. , 1995, Cancer research.

[53]  E. Holm,et al.  Protein metabolism in human colon carcinomas: in vivo investigations using a modified tracer technique with L-[1-13C]leucine. , 1995, Cancer research.

[54]  E. C. Bartels,et al.  Evaluation of the thyroid nodule. , 1962, The Surgical clinics of North America.

[55]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[56]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[57]  M. Said.  Thyroid Tumor Marker Genomics and Proteomics: Diagnostic and Clinical Implications , 2011 .

[58]  Rachel Cavill,et al.  Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). , 2009, Journal of proteome research.

[59]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[60]  Douglas B. Evans,et al.  Thyroid Cancer: 1999 Update and Evaluation of Solitary Thyroid Nodules , 2000, Annals of Surgical Oncology.

[61]  D. Tyler,et al.  Thyroid cancer: 1999 update. , 2000, Annals of surgical oncology.

[62]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[63]  H. Szymańska.  [Diagnosis and therapy]. , 1980, Pielegniarka i polozna.